TERESITA BRIONES-RAMILO: Open Payments
NPI 1144216060 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,665 in 114 payments from 18 companies in 2025. Trend: 2023 $519 · 2024 $1,566 · 2025 $1,665
Food & beverage: $1,558Education: $107
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 22 | $332 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $285 |
| Supernus Pharmaceuticals, Inc. | 23 | $229 |
| Otsuka America Pharmaceutical, Inc. | 14 | $203 |
| Janssen Pharmaceuticals, Inc | 4 | $73 |
| Axsome Therapeutics, Inc. | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 4 | $70 |
| Corium, LLC | 6 | $57 |
| Alkermes, Inc. | 3 | $56 |
| Collegium Pharmaceutical, Inc. | 3 | $52 |
Products named: FANAPT, CAPLYTA, Qelbree, REXULTI, SPRAVATO, Auvelity, Azstarys, ARISTADA.
Industry payments across IN — which companies pay providers there.
